Medicines for Malaria Venture’s Post

Urgent action needed at a policy, research, and legislative level on antibiotic regulations in Pakistan

Department of Health and Social Care have launched a new plan to tackle antimicrobial resistance (AMR). This national action plan commits the #UK to: 🔵 reduce use of antimicrobials 🔵 strengthen surveillance of drug resistant infections before they emerge 🔵 incentivise industry to develop the next generation of vaccines, diagnostics and therapies  bioMérieux UKI are committed to supporting the UK’s ambition to ‘confronting Antimicrobial Resistance’ by continuing to spread awareness of this topic to the wider public and also by supporting laboratories and clinicians by providing earlier, optimised and data-driven therapy through rapid diagnostics for better patient management and responsible use of antibiotics. Time is of the essence in the fight against #AMR and a collaborative and "One Health" approach across all stakeholders is essential if we are to meet this challenge head on. This UK National Action Plan (NAP) marks an important next step towards achieving a 20-year vision of a world in which AMR is contained, controlled, and mitigated. The time to act is now! https://lnkd.in/gzQ-s-vp #AntimicrobialResistance #optimisediagnostics #optimisetherapy #ODOT #ConfrontingAMR UK Research and Innovation Department for Science, Innovation and Technology UK Health Security Agency

We welcome the news that the Government has announced its new national action plan on antimicrobial resistance. This plan outlines the ambition and steps that will be taken over the next 5 years in support of the 20-year vision for antimicrobial resistance (AMR), with the ultimate aim of protecting people and animals from the growing threat posed by drug-resistant infections. You can read about the new 5-year plan here: https://lnkd.in/dhbKnPgK Dr Mike Murray, CEO of MetalloBio, commented: "The UK government continues to lead the globe with initiatives and policies aimed at addressing this massive problem - a problem that is already with us and to which we have as yet no convincing solutions. The key themes combine sensible approaches to managing currently available antibacterial drugs, with the recognition that many, many more new drug and non-drug treatment options need to be created. This is the core focus of MetalloBio as we advance completely new classes of antibiotic drug candidates to the clinic."

𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐑𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞: 𝐀 𝐠𝐥𝐨𝐛𝐚𝐥 𝐭𝐡𝐫𝐞𝐚𝐭 Ever heard of AMR? It's short for antimicrobial resistance, and it's a pretty big deal right now. Basically, it means that some germs are getting smarter. They're learning how to shrug off the antibiotics we throw at them, making infections tougher to beat. Antimicrobial resistance (AMR) is a pressing global health crisis that poses a significant threat to human health, food security, and economic development. It occurs when microorganisms, such as bacteria, viruses, fungi, and parasites, develop the ability to resist the effects of antimicrobial drugs. This means that the drugs that were once effective in treating infections are no longer as potent, making infections more difficult to treat and potentially leading to more severe outcomes. Read Full Blog: https://lnkd.in/gxmfs3yV

Once a background issue in #publichealth discussions, #AMR has emerged as a pressing challenge with the potential to reverse decades of medical progress. From #Nigeria to the #UnitedStates, from rural villages to bustling cities, #AMR affects us all. Yet, it often remains underappreciated by the general public—until its devastating consequences hit close to home. My article highlights how Antimicrobial Resistance should be a priority issue for all #Nigerians Addressing Antimicrobial Resistance Among Nigerians https://lnkd.in/dBHAYARQ

Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines, like antibiotics. Born with cystic fibrosis, Ella has been hospitalized with infections ever since she was little and says she “will continue to advocate until antimicrobial resistance is no longer the greatest threat to my life.” The World Health Organization’s "AMR is invisible, I am not" campaign puts advocates — like Ella from the WHO Task Force of AMR survivors — front and center, to share their stories, raise awareness, and urge action to address AMR. This growing threat is why we're committed to developing an inhaled therapeutic using EVQ-218 to address pulmonary bacterial infections linked to cystic fibrosis. We aim to support a future where patients like Ella can lead healthier lives. 🔗 https://lnkd.in/eNG_TZvn #AntimicrobialResistance #AMR #AMRsurvivors #AMRisInvisible #CysticFibrosis #FollowOurJourney

🌍 The rebellion of the antibiotic-resistant superbugs 🌍  https://lnkd.in/ev5z4-Gm   🎙️"The time may come when penicillin can be bought by anyone in the shops... then there is the danger that the ignorant man may easily underdose himself, and by exposing his microbes to the non-lethal quantities of the drug, make them resistant." 🎙️ #Alexander Fleming, Nobel Prize Speech, 1945.   Nearly 80 years later, Fleming’s chilling prediction is our reality: 70% of bacteria are now resistant to antibiotics. 😱 We’ve entered a world where infections defy treatment, and simple illnesses become threats.   Curious? Disturbed? Check out our new article on the antibiotic resistance crisis and answer the question: Are we ready to face the uprising of the superbugs? #Antibioticresistance #Superbugs #MDROs #multidrugresistantbacteria #Awareness #ImmunoWars

Antimicrobial resistance (AMR) is listed among the top 10 threats for global health by the World Health Organization, and could lead to 10 million deaths per year by 2050.   To help combat this global challenge, HBGI is partnering with PATH to create a results-based financing model to improve antibiotic stewardship (AMS) programs in low- and lower-middle income countries, starting in Senegal and Tanzania. We are currently working with PATH to develop an understanding of the economic and social incentives currently driving overuse or misuse of antibiotics, as well as the gaps in existing AMS programs. We expect to have a fully designed prototype funding model ready by the end of the year.   See below a policy brief from our partners at Wellcome Trust on how global leaders can come together to combat antimicrobial resistance (AMR).

Antimicrobial resistance is a critical threat to safety, health, and livelihoods across the globe. We need to engage new perspectives, new innovations, and the most powerful advances in #AI and #data to help protect the power of antibiotics. That’s why we’re proud to support The Trinity Challenge on Antimicrobial Resistance–offering a grand prize of up to £1m for innovators with a game-changing solution focused on low- and middle-income countries. You don’t need to be working in antimicrobial resistance to have a winning idea; the Challenge is a call to action across sectors and disciplines. Could you or your team have a winning solution? Learn more here: https://lnkd.in/ds7iqZFD

🌍 Antimicrobial Resistance (AMR) Awareness Week starts today under the theme: "Educate, Advocate, Act Now." AMR is a global health crisis that threatens the effective treatment of infections, jeopardizing medical advances and public health. Now, more than ever, we must come together to raise awareness, promote responsible use of antibiotics, and champion innovative solutions. 💡 Educate yourself and others about AMR. 📣 Advocate for better policies and practices to combat resistance. ⚡ Act Now to preserve the effectiveness of life-saving antimicrobials for future generations. Join the conversation, share your voice, and let’s make an impact together! 🌟 #AntimicrobialResistance #AMRAwareness #EducateAdvocateAct #OneHealth #GlobalHealth